注射ペンの市場：タイプ、用途、エンドユーザー、適応症別-2025-2030年の世界予測

注射ペン市場は、2023年に366億7,000万米ドルと評価され、2024年には391億9,000万米ドルに達すると予測され、CAGR 7.79％で成長し、2030年には620億2,000万米ドルに達すると予測されています。

注射ペン市場の範囲は、インスリン、成長ホルモン、生物学的製剤などの薬剤の自己投与に使用される医療機器として定義され、従来の注射器の代わりに使いやすいものを提供しています。このデバイスは、糖尿病のような慢性疾患への対応に必要であり、精度の向上と利便性により治療のアドヒアランスを促進するため、支持を集めています。注射ペンの用途は、主に内分泌学、腫瘍学、自己免疫疾患に焦点を当てた複数の治療分野にまたがっており、最終用途の範囲には病院、診療所、在宅ケアの現場が含まれ、患者の自立性とコンプライアンスを高めています。

市場の洞察によると、注射ペン市場は、慢性疾患の有病率の上昇、低侵襲ドラッグデリバリーデバイスの需要増加、スマートペン技術の技術進歩による投与精度の向上と患者モニタリングなどの要因によって成長を遂げています。バイオシミラーの需要急増や、製薬会社と機器メーカー間の提携拡大もビジネスチャンスです。このような機会を生かすため、企業は、高齢化社会のニーズや新興国市場における規制当局の承認に対応し、接続機能を強化した使いやすいデザインのペンの開発に注力することができます。

課題としては、先進的な注射ペンの高価格、新興国市場での認知度の低さ、機器の誤作動に関する潜在的な問題などがあり、これらは市場の成長を妨げる可能性があります。企業は競争力を維持するために、規制上のハードルを克服し、機器生産の持続可能性を確保するという課題に直面しています。イノベーションの機会は、ヘルスケアシステムとのより良い統合のためのペンのデジタルインターフェースの強化、持続可能な製造のための環境に優しい材料の開発、個別化ドラッグデリバリーのためのAIの組み込みにあります。市場の性質は競争が激しく進化しており、市場のリーダーシップを確保するためには患者中心のソリューションと規制遵守が重視されます。スマートペンのイノベーションのためにハイテク企業とのコラボレーションを促進し、強固な流通ネットワークを通じて市場への浸透を強化することは、事業成長の戦略的ルートとなり得る。

市場力学：急速に進化する注射ペン市場の主要市場インサイトを公開

注射ペン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患の有病率の上昇と承認件数の増加
  • 新興経済諸国における有利な償還と政府支援
  • 糖尿病患者によるインスリン投与用ペンの増加
• 市場抑制要因
  • 注射ペンに関連する高コスト
• 市場機会
  • 注射ペン需要の増加に伴う送達デバイス技術の開発
  • 研究開発への投資の増加
• 市場の課題
  • 他の治療方法への嗜好性

ポーターの5つの力：注射ペン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：注射ペン市場における外部からの影響の把握

外部マクロ環境要因は、注射ペン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析注射ペン市場における競合情勢の把握

注射ペン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス注射ペン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、注射ペン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨注射ペン市場における成功への道筋を描く

注射ペン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の罹患率の上昇と規制承認数の増加
    • 先進国における有利な償還と政府の支援
    • 糖尿病患者によるインスリン投与用のペンアプリが増加
  • 抑制要因
    • 注射ペンに関連する高コスト
  • 機会
    • 需要の高まりによるデリバリーデバイス技術の開発
    • 研究開発への投資の増加
  • 課題
    • 他の治療法を好む
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 注射ペンの市場：タイプ別

• 使い捨て
• 再利用可能なペン

第7章 注射ペンの市場：用途別

• 生殖能力
• 成長ホルモン療法
• インスリン投与
• 骨粗鬆症

第8章 注射ペンの市場：エンドユーザー別

• ホームケア
• 病院・クリニック

第9章 注射ペンの市場適応症別

• アナフィラキシー
• がん
• 心血管疾患
• 糖尿病
• 多発性硬化症
• 関節リウマチ

第10章 南北アメリカの注射ペンの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の注射ペンの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの注射ペンの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • アプターデジタルヘルスとSHLメディカルが提携し、接続性と患者体験の向上を通じて自己注射療法を強化
  • エーザイと日本メダック、関節リウマチ患者の利便性と安全性を高めるメトジェクト皮下注注射ペンを日本で発売
  • サノフィ・インドは、肥満成人を対象に血糖コントロールを改善し、低血糖リスクを軽減する糖尿病治療薬ソリクアを発売しました。
• 戦略分析と提言

企業一覧

• Amgen Inc.
• Antares Pharma, Inc.
• AstraZeneca plc
• Bayer AG
• Biocorp Production by Novo Nordisk
• Eli Lilly and Company
• F. Hoffmann-La Roche AG
• Gerresheimer AG
• Inolife Sciences Inc.
• Insulet Corporation
• Medtronic plc
• Mylan N.V.
• Nemera Development S.A.
• Novartis AG
• Novo Nordisk A/S
• Owen Mumford Ltd.
• Pfizer Inc.
• Sanofi S.A.
• SHL Medical AG
• Taiyo Pharma Co., Ltd.
• Terumo Corporation
• Teva Pharmaceuticals Industries Ltd.
• West Pharmaceutical Services, Inc.
• Wockhardt Limited
• Ypsomed AG

LIST OF FIGURES

• FIGURE 1. INJECTION PEN MARKET RESEARCH PROCESS
• FIGURE 2. INJECTION PEN MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL INJECTION PEN MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL INJECTION PEN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. INJECTION PEN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. INJECTION PEN MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL INJECTION PEN MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL INJECTION PEN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. INJECTION PEN MARKET DYNAMICS
• TABLE 7. GLOBAL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL INJECTION PEN MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL INJECTION PEN MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL INJECTION PEN MARKET SIZE, BY FERTILITY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL INJECTION PEN MARKET SIZE, BY GROWTH HORMONE THERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL INJECTION PEN MARKET SIZE, BY INSULIN DELIVERY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL INJECTION PEN MARKET SIZE, BY OSTEOPOROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL INJECTION PEN MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL INJECTION PEN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL INJECTION PEN MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL INJECTION PEN MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL INJECTION PEN MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL INJECTION PEN MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL INJECTION PEN MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL INJECTION PEN MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. CANADA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES INJECTION PEN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 60. CHINA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. CHINA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 63. CHINA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. INDIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 67. INDIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA INJECTION PEN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 133. ITALY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. ITALY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 136. ITALY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 149. POLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. POLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 152. POLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 153. QATAR INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 155. QATAR INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 156. QATAR INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM INJECTION PEN MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
• TABLE 193. INJECTION PEN MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. INJECTION PEN MARKET, FPNV POSITIONING MATRIX, 2023

The Injection Pen Market was valued at USD 36.67 billion in 2023, expected to reach USD 39.19 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 62.02 billion by 2030.

The scope of the injection pen market encompasses its definition as a medical device used for the self-administration of medication, such as insulin, growth hormones, and biologics, offering user-friendly alternatives to traditional syringes. This device is gaining traction due to its necessity in addressing chronic diseases like diabetes, facilitating treatment adherence through improved accuracy and convenience. The application of injection pens spans multiple therapeutic areas, primarily focusing on endocrinology, oncology, and autoimmune diseases, while the end-use scope includes hospitals, clinics, and home care settings, enhancing patient independence and compliance.

Market insights indicate that the injection pen market is experiencing growth driven by factors such as the rising prevalence of chronic diseases, increasing demand for minimally invasive drug delivery devices, and technological advances in smart pen technology, improving dosage precision and patient monitoring. Opportunities arise from the surge in demand for biosimilars and the expansion of partnerships between pharmaceutical companies and device manufacturers. To capitalize on these opportunities, companies could focus on developing pens with enhanced connectivity features and user-friendly designs, catering to an aging population's needs and regulatory approvals in emerging markets.

Challenges include the high cost of advanced injection pens, limited awareness in developing regions, and potential issues related to device malfunctions, which could hinder market growth. Companies face the task of overcoming regulatory hurdles and ensuring sustainability in device production to maintain competitiveness. Innovation opportunities lie in enhancing the pen's digital interface for better integration with healthcare systems, developing eco-friendly materials for sustainable manufacturing, and incorporating AI for personalized drug delivery. The market's nature is highly competitive and evolving, with an emphasis on patient-centric solutions and regulatory compliance to secure market leadership. Fostering collaborations with tech firms for smart pen innovations and enhancing market penetration through robust distribution networks could serve as strategic routes for business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Injection Pen Market

The Injection Pen Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of chronic diseases and growing number of regulatory approvals
  • Favorable reimbursement in developed economies and government support
  • Growing application pens by people with diabetes to administer insulin
• Market Restraints
  • High cost associated with injection pens
• Market Opportunities
  • Development of delivery device technology owing to rising injection pen demand
  • Growing investments toward research and development
• Market Challenges
  • Preference towards other modes of treatment

Porter's Five Forces: A Strategic Tool for Navigating the Injection Pen Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Injection Pen Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Injection Pen Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Injection Pen Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Injection Pen Market

A detailed market share analysis in the Injection Pen Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Injection Pen Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Injection Pen Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Injection Pen Market

A strategic analysis of the Injection Pen Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injection Pen Market, highlighting leading vendors and their innovative profiles. These include Amgen Inc., Antares Pharma, Inc., AstraZeneca plc, Bayer AG, Biocorp Production by Novo Nordisk, Eli Lilly and Company, F. Hoffmann-La Roche AG, Gerresheimer AG, Inolife Sciences Inc., Insulet Corporation, Medtronic plc, Mylan N.V., Nemera Development S.A., Novartis AG, Novo Nordisk A/S, Owen Mumford Ltd., Pfizer Inc., Sanofi S.A., SHL Medical AG, Taiyo Pharma Co., Ltd., Terumo Corporation, Teva Pharmaceuticals Industries Ltd., West Pharmaceutical Services, Inc., Wockhardt Limited, and Ypsomed AG.

Market Segmentation & Coverage

This research report categorizes the Injection Pen Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Disposable and Reusable Pens.
• Based on Application, market is studied across Fertility, Growth Hormone Therapy, Insulin Delivery, and Osteoporosis.
• Based on End User, market is studied across Homecare and Hospitals & Clinics.
• Based on Indication, market is studied across Anaphylaxis, Cancer, Cardiovascular Diseases, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of chronic diseases and growing number of regulatory approvals
    • 5.1.1.2. Favorable reimbursement in developed economies and government support
    • 5.1.1.3. Growing application pens by people with diabetes to administer insulin
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with injection pens
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of delivery device technology owing to rising injection pen demand
    • 5.1.3.2. Growing investments toward research and development
  • 5.1.4. Challenges
    • 5.1.4.1. Preference towards other modes of treatment
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Injection Pen Market, by Type

• 6.1. Introduction
• 6.2. Disposable
• 6.3. Reusable Pens

7. Injection Pen Market, by Application

• 7.1. Introduction
• 7.2. Fertility
• 7.3. Growth Hormone Therapy
• 7.4. Insulin Delivery
• 7.5. Osteoporosis

8. Injection Pen Market, by End User

• 8.1. Introduction
• 8.2. Homecare
• 8.3. Hospitals & Clinics

9. Injection Pen Market, by Indication

• 9.1. Introduction
• 9.2. Anaphylaxis
• 9.3. Cancer
• 9.4. Cardiovascular Diseases
• 9.5. Diabetes
• 9.6. Multiple Sclerosis
• 9.7. Rheumatoid Arthritis

10. Americas Injection Pen Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Injection Pen Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Injection Pen Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. Aptar Digital Health and SHL Medical partnership to enhance self-injectable therapies through enhanced connectivity and patient experience
  • 13.3.2. Eisai and nippon medac launch Metoject Subcutaneous Injection Pen in Japan to enhance convenience and safety for rheumatoid arthritis patients
  • 13.3.3. Sanofi India launched Soliqua, a daily diabetes injection pen targeting obese adults to improve glycaemic control and reduce hypoglycemia risk
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Amgen Inc.
• 2. Antares Pharma, Inc.
• 3. AstraZeneca plc
• 4. Bayer AG
• 5. Biocorp Production by Novo Nordisk
• 6. Eli Lilly and Company
• 7. F. Hoffmann-La Roche AG
• 8. Gerresheimer AG
• 9. Inolife Sciences Inc.
• 10. Insulet Corporation
• 11. Medtronic plc
• 12. Mylan N.V.
• 13. Nemera Development S.A.
• 14. Novartis AG
• 15. Novo Nordisk A/S
• 16. Owen Mumford Ltd.
• 17. Pfizer Inc.
• 18. Sanofi S.A.
• 19. SHL Medical AG
• 20. Taiyo Pharma Co., Ltd.
• 21. Terumo Corporation
• 22. Teva Pharmaceuticals Industries Ltd.
• 23. West Pharmaceutical Services, Inc.
• 24. Wockhardt Limited
• 25. Ypsomed AG